Small Pharma Inc.
DMTTF · OTC
5/31/2023 | 2/28/2023 | 11/30/2022 | 8/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $2 | $3 | $4 | $3 |
| G&A Expenses | $3 | $1 | $4 | $5 |
| SG&A Expenses | $3 | $1 | $4 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6 | $4 | $7 | $7 |
| Operating Income | -$6 | -$4 | -$7 | -$7 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$6 | -$4 | -$7 | -$7 |
| Tax Expense | $0 | -$2 | $0 | $0 |
| Net Income | -$6 | -$2 | -$7 | -$7 |
| % Margin | – | – | – | – |
| EPS | -0.018 | -0.007 | -0.022 | -0.023 |
| % Growth | -151.4% | 68.5% | 3.9% | – |
| EPS Diluted | -0.018 | -0.007 | -0.022 | -0.023 |
| Weighted Avg Shares Out | 322 | 321 | 322 | 322 |
| Weighted Avg Shares Out Dil | 322 | 321 | 322 | 322 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$6 | -$4 | -$7 | -$7 |
| % Margin | – | – | – | – |